Panacea Biotec to launch 7 anti-cancer products in 8 weeks

New Delhi, June 28 (UNI) Panacea Biotec Ltd today said it plans to launch seven anti-cancer products in the next eight weeks to provide treatment for breast cancer, brain tumor, ovarian cancer, pancreatic cancer, prostrate cancer and colorectal cancer.

''The aim is to register sales volumes of Rs 15-20 crore in oncology chemotherapy segment in the next three years,'' it said in a statement.

These drugs will be manufactured by a Mumbai-based company to be sold under the brand name Panacea.

Oncotrust would be the new Strategic Business Unit (SBU) of the company with the total strength of 50 sales specialists on oncology who would be responsible for marketing the drugs.

The company would also launch novel drug delivery based anti-cancer drug in next 2-3 years.

''We plan to develop novel and innovative drug delivery systems (NDDS) of the existing anti-cancer molecule. The new research-based drug development will take 2-3 years as we need to develop an effective distribution chain and occupy a significant market share in oncology drugs,'' company's Joint Managing Director Rajesh Jain said.

The company also plans to launch its injectable polio vaccine (IPV) in next three months in the private market and would gradually increase the market share after post-polio eradication programme of government.

UNI